1.38Open1.38Pre Close0 Volume6 Open Interest47.50Strike Price0.00Turnover5673.23%IV3.93%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry1.38Extrinsic Value100Contract SizeAmericanOptions Type0.4684Delta0.0987Gamma34.08Leverage Ratio-986.4307Theta0.0000Rho15.96Eff Leverage0.0003Vega
Viking Therapeutics Stock Discussion
loading...
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
🚀🚀🚀🚀 now all engines firing
No comment yet